The VTM Podcast - Episode 18 - Regenerative Medicine

Regenerative medicine in 2026 is moving from science-fiction promise toward real clinical impact—but the field is still defined by both breakthrough and caution. At its core, regenerative medicine asks one of the most ambitious questions in healthcare: what if medicine could not only treat disease, but repair, replace, or rebuild the body itself?

In this episode, we explore the state of regenerative medicine in 2026, from stem cell therapies and tissue engineering to gene therapy, cell therapy, organoids, exosomes, and 3D bioprinting. The field is no longer limited to the idea of “growing new organs” in a lab. Today, it includes living medicines designed to restore damaged tissue, reprogram immune cells, replace missing or defective cells, and potentially change the course of diseases once considered irreversible.